Ninety-day Readmission and Long-Term Mortality in Medicare Patients (≥65 Years) Treated With Ticagrelor Versus Prasugrel After Percutaneous Coronary Intervention (From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium)

Ticagrelor and prasugrel were found to be superior to clopidogrel for the treatment of acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI); however, the comparative effectiveness of these 2 drugs remains unknown. We compared post-discharge outcomes among older patients treat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Cardiol
Hlavní autoři: Song, Chris, Sukul, Devraj, Seth, Milan, Dupree, James M., Khandelwal, Akshay, Dixon, Simon R., Wohns, David, LaLonde, Thomas, Gurm, Hitinder S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850017/
https://ncbi.nlm.nih.gov/pubmed/29025684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2017.08.009
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky